EXECUTIVE ENGAGEMENTS
OUTREACH
13024
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
1563
Interactions with Platform & by Email
PARTICIPANTS
391
Unique # Participated
VALIDATIONS
176
Responses Validated*
COMPETITORS
64
Responses Validated*
* Login for a full stack data experience
DATE
APR 2021
TABLES
213
PAGES
307
EDITION
15
PRICE
USD $5600
HIGHLIGHTS
Amid the COVID-19 crisis, the global market for Intranasal Drug Delivery estimated at US$44.7 Billion in the year 2020, is projected to reach a revised size of US$59.2 Billion by 2027, growing at a CAGR of 4.1% over the analysis period 2020-2027. Spray, one of the segments analyzed in the report, is projected to record a 4.5% CAGR and reach US$19.7 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Drop segment is readjusted to a revised 5% CAGR for the next 7-year period.
The Intranasal Drug Delivery market in the U.S. is estimated at US$12.1 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$11.8 Billion by the year 2027 trailing a CAGR of 6.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.3% and 3.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 2.5% CAGR.
In the global Gel segment, USA, Canada, Japan, China and Europe will drive the 3.2% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$8 Billion in the year 2020 will reach a projected size of US$10 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$7.8 Billion by the year 2027, while Latin America will expand at a 4.5% CAGR through the analysis period.
SELECT PLAYERS
Aegis Therapeutics LLC; AptarGroup, Inc.; AstraZeneca Plc; Becton Dickinson and Company; GlaxoSmithKline Plc; Johnson & Johnson; Marina Biotech, Inc.; MedImmune, Inc.; Merck & Co., Inc.; Nemera; Novartis AG; OptiNose US Inc.; Pfizer Inc.; Valeant Pharmaceuticals International, Inc.
SEGMENTS
» Dosage Form (Spray, Drop, Gel, Powder) » Application (Nasal Congestion, Rhinitis, Asthma, Other Applications)
GEOGRAPHIES
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » Spain » Russia » and Rest of Europe » Asia-Pacific » Australia » India » South Korea » and Rest of Asia-Pacific » Latin America » Argentina » Brazil » Mexico » and Rest of Latin America » Middle East » Iran » Israel » Saudi Arabia » United Arab Emirates » and Rest of Middle East » and Africa
TABLE OF CONTENTS
| I. METHODOLOGY |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Influencer Market Insights |
| World Market Trajectories |
| Impact of Covid-19 and a Looming Global Recession |
| A Prelude |
| Intranasal Cavity: An Attractive Drug Delivery Route to Cross the Blood Brain Barrier |
| Recent Market Activity |
| Factors Inhibiting Nose-to-Brain Transportation of Drugs |
| Bioavailability: An Important Facet of Intranasal Drug Delivery |
| Outlook |
| Nasal Drug Delivery Devices & Equipment |
| Traditional Vs. Advanced Intranasal Drug Formulation Types |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| Burgeoning Geriatric Populace Spurs Growing Demand for Intranasal Drug Therapies |
| Nasal Drug Delivery Offers New Opportunities for Drug Developers as Patent Cliffs Usher in Dusk of Blockbuster Era |
| Pharmaceutical and Medical Device Companies Vying to Develop New Intranasal Therapeutics for Allergic Rhinitis Patients |
| The US - FDA Approved Intranasal Corticosteroids (INAC) and Intranasal Antihistamines (INAH) for Treating Allergic Rhinitis |
| The US - FDA Approved Nasal Spray Medication Types (excluding INAC & INAH) for Allergic Rhinitis Treatment |
| The US - FDA Approved Intranasal Corticosteroids (INAC) and Intranasal Antihistamines (INAH) for Treating Allergic Rhinitis |
| The US - FDA Approved Nasal Spray Medication Types (excluding INAC & INAH) for Allergic Rhinitis Treatment |
| Intranasal Corticosteroids - A Potential Treatment for Debilitating Chronic Rhinosinusitis Disease |
| Self-Administration of Drugs Brings Intranasal Drug Delivery into the Spotlight |
| Innovation in Drug Delivery: A Talisman for Success |
| Active Pharmaceutical Ingredients Used in Formulations for Nasal Drug Delivery with Related Indications |
| Controlled Release Technology Is the Buzz Word |
| Increasing R&D Unlocks New Therapeutic Areas for Nasal Drug Delivery |
| Tight Junction Biology: A Key Speed Breaker in Commercialization |
| RNA Interference (RNAi): A Tool to Manipulate Tight Junctions |
| Research Studies Authenticate Benefits of Bi-Directional Nasal Drug Delivery |
| Growing Interest for Preservative-free Nasal Spray Formulations |
| Multi-Dose Containers Developed to Offer Resistance against Microbial Contamination |
| 4. GLOBAL MARKET PERSPECTIVE |
| World Current & Future Analysis for Intranasal Drug Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Intranasal Drug Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Intranasal Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Spray by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Spray by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Spray by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Drop by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Drop by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Drop by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Gel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Gel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Gel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Powder by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Powder by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Powder by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Nasal Congestion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Nasal Congestion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Nasal Congestion by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Rhinitis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Rhinitis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Rhinitis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Asthma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Asthma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Asthma by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| III. MARKET ANALYSIS |
| UNITED STATES |
| USA Current & Future Analysis for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Intranasal Drug Delivery by Dosage Form - Percentage Breakdown of Value Sales for Spray, Drop, Gel and Powder for the Years 2012, 2020 & 2027 |
| USA Current & Future Analysis for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Nasal Congestion, Rhinitis, Asthma and Other Applications for the Years 2012, 2020 & 2027 |
| CANADA |
| Canada Current & Future Analysis for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Intranasal Drug Delivery by Dosage Form - Percentage Breakdown of Value Sales for Spray, Drop, Gel and Powder for the Years 2012, 2020 & 2027 |
| Canada Current & Future Analysis for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Nasal Congestion, Rhinitis, Asthma and Other Applications for the Years 2012, 2020 & 2027 |
| JAPAN |
| Japan Current & Future Analysis for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Intranasal Drug Delivery by Dosage Form - Percentage Breakdown of Value Sales for Spray, Drop, Gel and Powder for the Years 2012, 2020 & 2027 |
| Japan Current & Future Analysis for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Nasal Congestion, Rhinitis, Asthma and Other Applications for the Years 2012, 2020 & 2027 |
| CHINA |
| China Current & Future Analysis for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Intranasal Drug Delivery by Dosage Form - Percentage Breakdown of Value Sales for Spray, Drop, Gel and Powder for the Years 2012, 2020 & 2027 |
| China Current & Future Analysis for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Nasal Congestion, Rhinitis, Asthma and Other Applications for the Years 2012, 2020 & 2027 |
| EUROPE |
| Europe Current & Future Analysis for Intranasal Drug Delivery by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Intranasal Drug Delivery by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Intranasal Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Intranasal Drug Delivery by Dosage Form - Percentage Breakdown of Value Sales for Spray, Drop, Gel and Powder for the Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Nasal Congestion, Rhinitis, Asthma and Other Applications for the Years 2012, 2020 & 2027 |
| FRANCE |
| France Current & Future Analysis for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Intranasal Drug Delivery by Dosage Form - Percentage Breakdown of Value Sales for Spray, Drop, Gel and Powder for the Years 2012, 2020 & 2027 |
| France Current & Future Analysis for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Nasal Congestion, Rhinitis, Asthma and Other Applications for the Years 2012, 2020 & 2027 |
| GERMANY |
| Germany Current & Future Analysis for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Intranasal Drug Delivery by Dosage Form - Percentage Breakdown of Value Sales for Spray, Drop, Gel and Powder for the Years 2012, 2020 & 2027 |
| Germany Current & Future Analysis for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Nasal Congestion, Rhinitis, Asthma and Other Applications for the Years 2012, 2020 & 2027 |
| ITALY |
| Italy Current & Future Analysis for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Intranasal Drug Delivery by Dosage Form - Percentage Breakdown of Value Sales for Spray, Drop, Gel and Powder for the Years 2012, 2020 & 2027 |
| Italy Current & Future Analysis for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Nasal Congestion, Rhinitis, Asthma and Other Applications for the Years 2012, 2020 & 2027 |
| UNITED KINGDOM |
| UK Current & Future Analysis for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Intranasal Drug Delivery by Dosage Form - Percentage Breakdown of Value Sales for Spray, Drop, Gel and Powder for the Years 2012, 2020 & 2027 |
| UK Current & Future Analysis for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Nasal Congestion, Rhinitis, Asthma and Other Applications for the Years 2012, 2020 & 2027 |
| SPAIN |
| Spain Current & Future Analysis for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Spain Historic Review for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Spain 15-Year Perspective for Intranasal Drug Delivery by Dosage Form - Percentage Breakdown of Value Sales for Spray, Drop, Gel and Powder for the Years 2012, 2020 & 2027 |
| Spain Current & Future Analysis for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Spain Historic Review for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Spain 15-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Nasal Congestion, Rhinitis, Asthma and Other Applications for the Years 2012, 2020 & 2027 |
| RUSSIA |
| Russia Current & Future Analysis for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Russia Historic Review for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Russia 15-Year Perspective for Intranasal Drug Delivery by Dosage Form - Percentage Breakdown of Value Sales for Spray, Drop, Gel and Powder for the Years 2012, 2020 & 2027 |
| Russia Current & Future Analysis for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Russia Historic Review for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Russia 15-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Nasal Congestion, Rhinitis, Asthma and Other Applications for the Years 2012, 2020 & 2027 |
| REST OF EUROPE |
| Rest of Europe Current & Future Analysis for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Intranasal Drug Delivery by Dosage Form - Percentage Breakdown of Value Sales for Spray, Drop, Gel and Powder for the Years 2012, 2020 & 2027 |
| Rest of Europe Current & Future Analysis for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Nasal Congestion, Rhinitis, Asthma and Other Applications for the Years 2012, 2020 & 2027 |
| ASIA-PACIFIC |
| Asia-Pacific Current & Future Analysis for Intranasal Drug Delivery by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Intranasal Drug Delivery by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Intranasal Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2020 & 2027 |
| Asia-Pacific Current & Future Analysis for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Intranasal Drug Delivery by Dosage Form - Percentage Breakdown of Value Sales for Spray, Drop, Gel and Powder for the Years 2012, 2020 & 2027 |
| Asia-Pacific Current & Future Analysis for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Nasal Congestion, Rhinitis, Asthma and Other Applications for the Years 2012, 2020 & 2027 |
| AUSTRALIA |
| Australia Current & Future Analysis for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Australia Historic Review for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Australia 15-Year Perspective for Intranasal Drug Delivery by Dosage Form - Percentage Breakdown of Value Sales for Spray, Drop, Gel and Powder for the Years 2012, 2020 & 2027 |
| Australia Current & Future Analysis for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Australia Historic Review for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Australia 15-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Nasal Congestion, Rhinitis, Asthma and Other Applications for the Years 2012, 2020 & 2027 |
| INDIA |
| India Current & Future Analysis for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| India Historic Review for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| India 15-Year Perspective for Intranasal Drug Delivery by Dosage Form - Percentage Breakdown of Value Sales for Spray, Drop, Gel and Powder for the Years 2012, 2020 & 2027 |
| India Current & Future Analysis for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| India Historic Review for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| India 15-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Nasal Congestion, Rhinitis, Asthma and Other Applications for the Years 2012, 2020 & 2027 |
| SOUTH KOREA |
| South Korea Current & Future Analysis for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| South Korea Historic Review for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| South Korea 15-Year Perspective for Intranasal Drug Delivery by Dosage Form - Percentage Breakdown of Value Sales for Spray, Drop, Gel and Powder for the Years 2012, 2020 & 2027 |
| South Korea Current & Future Analysis for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| South Korea Historic Review for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| South Korea 15-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Nasal Congestion, Rhinitis, Asthma and Other Applications for the Years 2012, 2020 & 2027 |
| REST OF ASIA-PACIFIC |
| Rest of Asia-Pacific Current & Future Analysis for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Asia-Pacific Historic Review for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Asia-Pacific 15-Year Perspective for Intranasal Drug Delivery by Dosage Form - Percentage Breakdown of Value Sales for Spray, Drop, Gel and Powder for the Years 2012, 2020 & 2027 |
| Rest of Asia-Pacific Current & Future Analysis for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Asia-Pacific Historic Review for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Asia-Pacific 15-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Nasal Congestion, Rhinitis, Asthma and Other Applications for the Years 2012, 2020 & 2027 |
| LATIN AMERICA |
| Latin America Current & Future Analysis for Intranasal Drug Delivery by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| Latin America Historic Review for Intranasal Drug Delivery by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Latin America 15-Year Perspective for Intranasal Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2020 & 2027 |
| Latin America Current & Future Analysis for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Latin America Historic Review for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Latin America 15-Year Perspective for Intranasal Drug Delivery by Dosage Form - Percentage Breakdown of Value Sales for Spray, Drop, Gel and Powder for the Years 2012, 2020 & 2027 |
| Latin America Current & Future Analysis for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Latin America Historic Review for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Latin America 15-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Nasal Congestion, Rhinitis, Asthma and Other Applications for the Years 2012, 2020 & 2027 |
| ARGENTINA |
| Argentina Current & Future Analysis for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Argentina Historic Review for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Argentina 15-Year Perspective for Intranasal Drug Delivery by Dosage Form - Percentage Breakdown of Value Sales for Spray, Drop, Gel and Powder for the Years 2012, 2020 & 2027 |
| Argentina Current & Future Analysis for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Argentina Historic Review for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Argentina 15-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Nasal Congestion, Rhinitis, Asthma and Other Applications for the Years 2012, 2020 & 2027 |
| BRAZIL |
| Brazil Current & Future Analysis for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Brazil Historic Review for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Brazil 15-Year Perspective for Intranasal Drug Delivery by Dosage Form - Percentage Breakdown of Value Sales for Spray, Drop, Gel and Powder for the Years 2012, 2020 & 2027 |
| Brazil Current & Future Analysis for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Brazil Historic Review for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Brazil 15-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Nasal Congestion, Rhinitis, Asthma and Other Applications for the Years 2012, 2020 & 2027 |
| MEXICO |
| Mexico Current & Future Analysis for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Mexico Historic Review for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Mexico 15-Year Perspective for Intranasal Drug Delivery by Dosage Form - Percentage Breakdown of Value Sales for Spray, Drop, Gel and Powder for the Years 2012, 2020 & 2027 |
| Mexico Current & Future Analysis for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Mexico Historic Review for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Mexico 15-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Nasal Congestion, Rhinitis, Asthma and Other Applications for the Years 2012, 2020 & 2027 |
| REST OF LATIN AMERICA |
| Rest of Latin America Current & Future Analysis for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Latin America Historic Review for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Latin America 15-Year Perspective for Intranasal Drug Delivery by Dosage Form - Percentage Breakdown of Value Sales for Spray, Drop, Gel and Powder for the Years 2012, 2020 & 2027 |
| Rest of Latin America Current & Future Analysis for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Latin America Historic Review for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Latin America 15-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Nasal Congestion, Rhinitis, Asthma and Other Applications for the Years 2012, 2020 & 2027 |
| MIDDLE EAST |
| Middle East Current & Future Analysis for Intranasal Drug Delivery by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| Middle East Historic Review for Intranasal Drug Delivery by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Middle East 15-Year Perspective for Intranasal Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2020 & 2027 |
| Middle East Current & Future Analysis for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Middle East Historic Review for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Middle East 15-Year Perspective for Intranasal Drug Delivery by Dosage Form - Percentage Breakdown of Value Sales for Spray, Drop, Gel and Powder for the Years 2012, 2020 & 2027 |
| Middle East Current & Future Analysis for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Middle East Historic Review for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Middle East 15-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Nasal Congestion, Rhinitis, Asthma and Other Applications for the Years 2012, 2020 & 2027 |
| IRAN |
| Iran Current & Future Analysis for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Iran Historic Review for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Iran 15-Year Perspective for Intranasal Drug Delivery by Dosage Form - Percentage Breakdown of Value Sales for Spray, Drop, Gel and Powder for the Years 2012, 2020 & 2027 |
| Iran Current & Future Analysis for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Iran Historic Review for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Iran 15-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Nasal Congestion, Rhinitis, Asthma and Other Applications for the Years 2012, 2020 & 2027 |
| ISRAEL |
| Israel Current & Future Analysis for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Israel Historic Review for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Israel 15-Year Perspective for Intranasal Drug Delivery by Dosage Form - Percentage Breakdown of Value Sales for Spray, Drop, Gel and Powder for the Years 2012, 2020 & 2027 |
| Israel Current & Future Analysis for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Israel Historic Review for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Israel 15-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Nasal Congestion, Rhinitis, Asthma and Other Applications for the Years 2012, 2020 & 2027 |
| SAUDI ARABIA |
| Saudi Arabia Current & Future Analysis for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Saudi Arabia Historic Review for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Saudi Arabia 15-Year Perspective for Intranasal Drug Delivery by Dosage Form - Percentage Breakdown of Value Sales for Spray, Drop, Gel and Powder for the Years 2012, 2020 & 2027 |
| Saudi Arabia Current & Future Analysis for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Saudi Arabia Historic Review for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Saudi Arabia 15-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Nasal Congestion, Rhinitis, Asthma and Other Applications for the Years 2012, 2020 & 2027 |
| UNITED ARAB EMIRATES |
| UAE Current & Future Analysis for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UAE Historic Review for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| UAE 15-Year Perspective for Intranasal Drug Delivery by Dosage Form - Percentage Breakdown of Value Sales for Spray, Drop, Gel and Powder for the Years 2012, 2020 & 2027 |
| UAE Current & Future Analysis for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UAE Historic Review for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| UAE 15-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Nasal Congestion, Rhinitis, Asthma and Other Applications for the Years 2012, 2020 & 2027 |
| REST OF MIDDLE EAST |
| Rest of Middle East Current & Future Analysis for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Middle East Historic Review for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Middle East 15-Year Perspective for Intranasal Drug Delivery by Dosage Form - Percentage Breakdown of Value Sales for Spray, Drop, Gel and Powder for the Years 2012, 2020 & 2027 |
| Rest of Middle East Current & Future Analysis for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Middle East Historic Review for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Middle East 15-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Nasal Congestion, Rhinitis, Asthma and Other Applications for the Years 2012, 2020 & 2027 |
| AFRICA |
| Africa Current & Future Analysis for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Africa Historic Review for Intranasal Drug Delivery by Dosage Form - Spray, Drop, Gel and Powder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Africa 15-Year Perspective for Intranasal Drug Delivery by Dosage Form - Percentage Breakdown of Value Sales for Spray, Drop, Gel and Powder for the Years 2012, 2020 & 2027 |
| Africa Current & Future Analysis for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Africa Historic Review for Intranasal Drug Delivery by Application - Nasal Congestion, Rhinitis, Asthma and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Africa 15-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Nasal Congestion, Rhinitis, Asthma and Other Applications for the Years 2012, 2020 & 2027 |
| IV. COMPETITION |
| Total Companies Profiled: 64 |
Focus On Spray, One of the Largest Segments in the Intranasal Drug Delivery Market.
Will this Market be a Huge Opportunity by 2025?
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com